Specialized honored to have Cavendish back
Sinyard regrets losing Leipheimer





Behind every star rider is the manufacturer that produces the machine they ride to glory, and few bike company/rider relationships have been writt🥀en about more than that between Mark Cavendish and Specialized.
Specialized ends sponsorship �🐟�agreement with Quick Step
168𝐆澳洲5最新开奖结果:Specialized takes the Highro♔ad with HTC
168澳洲5最新开奖结果:Cavendish to Omega Pharma-QuickStep?
Specialized helps 🔯Leipheimer's decision to sign with Omega Pharma-Quick Step
168澳洲5最新开奖结果:Team Sky to ride Specia𝄹lized bikes in 2013?
168澳洲5最新开奖结果:Cavendish to Omega Pಞharma – Quick Step?
168澳洲5最新开奖结果:Cavendish: It can't work with Sky
168澳洲5最新ꦇ开奖结果:Cavendish confirmed for Omega Pharma-Quickst♏ep
After one season on Pinarello and Team Sky, 168澳洲5最新开奖结果:Cavendish will now return 🌄to the American company which produced his Tour de France stage winning chariots in 2010 and 2011 when he joins Omega Pharma-QuickStep in 2013 for ꦉthree full seasons.
The company has had a history of shifting its alliance with teams in order to keep specific riders on its brand: after 2009, it 168澳洲5最新开奖结果:dropped QuickStep in order to 168澳洲5最新开奖结果:add Cavendish's HTC-Highroad team to its portfolio. At the time it already supported the Astana tea🃏m of Alberto Contador as well as Saxo Bank and Andy Schleck.
Each time when Cavendish was looking to leave his team: in 2011, Highroad, and earlier this year Sky, it was heavily rumoured that the company would either 168澳洲5最新开奖结果:try to usurp Pinarello on Team Sky or buy out ওCavendish to bring him to QuickStep.
Specialized founder and CEO Mike Sinyard would not comment on the specifics but said that Specialized was involved in bringing Cavendi💜sh to the Omega Pharma-QuickS🌸tep team, and said he and the company are "very honored to work with him again".
"When we worked with him in the past he was 🐼really good, he gave great product feedback and challenged us in a good way. He's got a lot of energy and a lot of ideas, and personally we relate very much to Mark. It's a big honor to have Mark choose to come back to Specialized."
Sinyard said that in the past, Cavendish worked closely with hisꦡ product development t𒀰eam to help build race-winning machines such as the Venge, and he expects no less in the future relationship.
The latest ra♒ce content, interviews, features, reviews and expert buying guides, direct to your inbox!
"We are look forward to rea🧔lly going out there and be challengedও in a great way to make the product to help him win," Sinyard said.
The announcement comes on the heels of much less exciting news for Sin﷽yard, when the Omega Pharma-QuickStep team announced it had terminated the contract of Levi Leipheimer, who was suspended for six months for admitting to past doping while testifying for the USADA case against Lance Armstrong.
Even though Cavendish chose to head to Sky for the 2012 season, Sinyard's company got behind the growing Omega Pharma-QuickStep team, helping to smooth a deal for t♏he team to bring in Leipheimeꦗr after he was not renewed with RadioShack.
It has since emerged 🌳tಌhat RadioShack would not re-sign Leipheimer because he had testified to the federal grand jury in its investigation of Lance Armstrong.
Sinyard said he had respect for ☂Leipheimer's admissions, but also respected the decision of the team in letting him go.
"Any one who knows Levi knows he's one of the most genuine, real people around. He's ✨a great ambassador for the sport.
"I underst🦄and where the team is coming from, and I respect their decision, but at the same time I feel very sad that that happened."

Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Managing Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore l𒈔esser traveled roads, paths and gravel tracks. Laura specialises in covering doping, anti-doping, UCI governance and performing data analysis.